We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DCL Medical Laboratories Sold to Laboratory Corporation of America

By LabMedica International staff writers
Posted on 28 Jul 2010
Thompson Street Capital Partners (St. More...
Louis, MO, USA) have sold DCL Medical Laboratories, LLC (DCL) to Laboratory Corporation of America Holdings (LabCorp; Burlington, NC, USA), a U.S. provider of medical laboratory tests and services. Terms of the transaction were not disclosed.

DCL provides diagnostic and clinical trial testing services to physicians, hospitals, and pharmaceutical and medical device companies. The company provides anatomic pathology as well as clinical trial testing services and specializes in women's health.

LabCorp offers clinical assays ranging from routine blood analysis to HIV and genomic testing. DCL will join LabCorp's nationwide network of 38 primary testing locations and its industry-leading Centers of Excellence laboratories, including the Center for Esoteric Testing, Viro-Med, National Genetics Institute and US Labs.

In 2007, Thompson Street, together with Jack Bergstrom and Jay Tyler, acquired DCL from its founders. The goal of the transaction was to capitalize and expand the company's strong reputation in women's health. Thompson Street's managing partner, Jim Cooper, said, "We achieved this by growing our sales force and laboratory staff, increasing our participation in pharmaceutical and medical device clinical trials, and investing in our laboratory IT and test equipment infrastructure."

Related Links:
Thompson Street Capital Partners
Laboratory Corporation of America Holdings


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.